Home Markets Merck Sells Direct Holding In Moderna – Quick Facts

Merck Sells Direct Holding In Moderna – Quick Facts

2
investorsdiurnal business news magazine

This post was originally published on this site

(RTTNews) – Merck (MRK) has divested its direct holding in Moderna (MRNA) in the first half of the fourth quarter. As a result, Merck expects to record a small fourth-quarter gain. Merck noted that the company retains exposure to Moderna indirectly through its investment in venture funds.

Merck's direct investment in MRNA was initiated in…